Staging non-small cell lung cancer with whole-body PET.
暂无分享,去创建一个
P C Goodman | R. Coleman | J. Herndon | E. Patz | J. Erasmus | P. Goodman | H. McAdams | E. Marom | R E Coleman | E M Marom | J J Erasmus | E F Patz | H P McAdams | D K Culhane | J E Herndon | D. Culhane
[1] E. van Marck,et al. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. , 1997, The European respiratory journal.
[2] J. Doppman,et al. Adrenal masses differentiated by MR. , 1986, Radiology.
[3] C. Baamonde,et al. Extrathoracic staging of bronchogenic carcinoma. , 1990, Chest.
[4] L E Quint,et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. , 1996, AJR. American journal of roentgenology.
[5] R. Ginsberg,et al. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy , 1996 .
[6] M P Sandler,et al. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. , 1998, Archives of surgery.
[7] K. Yokoi,et al. Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography. , 1996, The Annals of thoracic surgery.
[8] R. Coleman,et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.
[9] P. Boccato,et al. « Cyto-Assisted », Ultrasound-Guided Biopsy in the Diagnosis of Focal Disease of the Abdomen , 1991, Tumori.
[10] R. Tarver,et al. Cerebral metastases from lung carcinoma: neurological and CT correlation. Work in progress. , 1984, Radiology.
[11] J. Wittenberg,et al. Triangulation method for percutaneous needle guidance: the angled approach to upper abdominal masses. , 1981, AJR. American journal of roentgenology.
[12] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[13] R. Coleman,et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. , 1997, AJR. American journal of roentgenology.
[14] R. Hustinx,et al. Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] G. V. von Schulthess,et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. , 1997, Radiology.
[16] H. Abdel-Nabi,et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. , 1998, Radiology.
[17] D. E. Jackson,et al. Staging of non-small cell bronchogenic carcinoma. Relationship of the clinical evaluation to organ scans. , 1986, Chest.
[18] J. Herndon,et al. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax. , 1999, Radiology.
[19] P. Valk,et al. Cost-effectiveness of PET imaging in clinical oncology. , 1996, Nuclear medicine and biology.
[20] T G Turkington,et al. Performance characteristics of a whole-body PET scanner. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] Taylor Murray,et al. Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.
[22] M. Maisey,et al. FDG‐PET screening for cerebral metastases in patients with suspected malignancy , 1996, Nuclear medicine communications.
[23] R. Hustinx,et al. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. , 1997, The European respiratory journal.
[24] K. Yasumoto,et al. Combined thoracoscopy and mediastinoscopy for mediastinal lymph node staging of lung cancer. , 1996, International surgery.
[25] E. Kazerooni,et al. Percutaneous CT‐Guided Biopsy of Adrenal Masses: Immediate and Delayed Complications , 1995, Journal of computer assisted tomography.
[26] S S Gambhir,et al. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] P. Marsden,et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer , 1994, The Lancet.
[28] G. Marchal,et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[29] D Delbeke,et al. Prospective investigation of positron emission tomography in lung nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] V. M. Phillips,et al. CT-guided adrenal biopsy: accuracy, safety, and indications. , 1985, AJR. American journal of roentgenology.
[31] Current applications of imaging procedures in the patient with lung cancer. , 1991, International journal of radiation oncology, biology, physics.
[32] P. Valk,et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. , 1995, The Annals of thoracic surgery.
[33] J. Macfie,et al. Diagnosis of abdominal masses with percutaneous biopsy guided by ultrasound. , 1990, BMJ.
[34] M. Bernardino,et al. Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. , 1984, Radiology.